Watch Ticker

SAB Biotherapeutics, Inc. Warrant

Go to SAB Biotherapeutics, Inc. Warrant Website

$0.03

0.00 (0.00%)

Live

Previous Close

$0.0255

Day Range

$0 - $0

Previous Day Range

$0.0253 - $0.0291

Market Cap

$ USD

Day Vol.

Previous Day Vol.

55366

Currency

USD

Primary Exchange

Nasdaq

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, witho...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - SAB BIO Announces Q1 2025 Financial Results and Provides Company Updates

SAB BIO, a clinical-stage biopharmaceutical company, reported financial results for Q1 2025. The company made progress on its type 1 diabetes program, including positive Phase 1 data for its lead candidate SAB-142. SAB BIO also achieved manufacturing milestones and saw a decrease in R&D and G&A expenses.

Related tickers: SABS, SABSW.

Read Full Article

N/A - SAB BIO to Participate in Upcoming Investor Conferences

SAB BIO, a clinical-stage biopharmaceutical company, announced its participation in upcoming investor conferences to discuss its lead asset, SAB-142, which targets type 1 diabetes with a disease-modifying approach.

Related tickers: SABS, SABSW.

Read Full Article

Trending Tickers

Please sign in to view